These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 1438977)
1. Vasoactive intestinal polypeptide (VIP) inhibits rat alveolar macrophage phagocytosis and chemotaxis in vitro. Litwin DK; Wilson AK; Said SI Regul Pept; 1992 Jul; 40(1):63-74. PubMed ID: 1438977 [TBL] [Abstract][Full Text] [Related]
2. Stimulation by vasoactive intestinal peptide (VIP) of phagocytic function in rat macrophages. Protein kinase C involvement. De la Fuente M; Delgado M; del Rio M; Martinez C; Hernanz A; Gomariz RP Regul Pept; 1993 Nov; 48(3):345-53. PubMed ID: 8278627 [TBL] [Abstract][Full Text] [Related]
3. Characterization of vasoactive intestinal peptide receptors on rat alveolar macrophages. Sakakibara H; Shima K; Said SI Am J Physiol; 1994 Sep; 267(3 Pt 1):L256-62. PubMed ID: 7943252 [TBL] [Abstract][Full Text] [Related]
4. Role of alveolar macrophage chemotaxis and phagocytosis in pulmonary clearance responses to inhaled particles: comparisons among rodent species. Warheit DB; Hartsky MA Microsc Res Tech; 1993 Dec; 26(5):412-22. PubMed ID: 8286787 [TBL] [Abstract][Full Text] [Related]
5. Serine/threonine phosphorylation in cellular signaling for alveolar macrophage phagocytic response to endotoxin. Zhang P; Nelson S; Summer WR; Spitzer JA Shock; 2000 Jan; 13(1):34-40. PubMed ID: 10638667 [TBL] [Abstract][Full Text] [Related]
6. Vasoactive intestinal peptide modulation of adherence and mobility in rat peritoneal lymphocytes and macrophages. de la Fuente M; Delgado M; del Rio M; Garrido E; Leceta J; Hernanz A; Gomariz RP Peptides; 1994; 15(7):1157-63. PubMed ID: 7854966 [TBL] [Abstract][Full Text] [Related]
7. VIP activates G(s) and G(i3) in rat alveolar macrophages and G(s) in HEK293 cells transfected with the human VPAC(1) receptor. Shreeve SM; Sreedharan SP; Hacker MP; Gannon DE; Morgan MJ Biochem Biophys Res Commun; 2000 Jun; 272(3):922-8. PubMed ID: 10860852 [TBL] [Abstract][Full Text] [Related]
8. The effect of endotoxin on in vivo rat alveolar macrophage phagocytosis. Frevert CW; Warner AE; Weller E; Brain JD Exp Lung Res; 1998; 24(6):745-58. PubMed ID: 9839162 [TBL] [Abstract][Full Text] [Related]
9. Vasoactive intestinal polypeptide as possible mediator of relaxation in the rat gastric fundus. De Beurme FA; Lefebvre RA J Pharm Pharmacol; 1988 Oct; 40(10):711-5. PubMed ID: 2907538 [TBL] [Abstract][Full Text] [Related]
10. Vagal release of vasoactive intestinal peptide can promote vagotonic tachycardia in the isolated innervated rat heart. Shvilkin A; Danilo P; Chevalier P; Chang F; Cohen IS; Rosen MR Cardiovasc Res; 1994 Dec; 28(12):1769-73. PubMed ID: 7867028 [TBL] [Abstract][Full Text] [Related]
11. Coronary vascular effects of vasoactive intestinal peptide in the isolated perfused rat heart. Sawmiller DR; Henning RJ; Cuevas J; Dehaven WI; Vesely DL Neuropeptides; 2004 Oct; 38(5):289-97. PubMed ID: 15464194 [TBL] [Abstract][Full Text] [Related]
12. [Effects of vasoactive intestinal peptide on chemotaxis of bronchial epithelial cells]. Guan CX; Zhang CQ; Qin XQ; Luo ZQ; Zhou FW; Sun XH Sheng Li Xue Bao; 2002 Apr; 54(2):103-6. PubMed ID: 11973586 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of endotoxin-induced macrophage chemokine production by vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in vitro and in vivo. Delgado M; Ganea D J Immunol; 2001 Jul; 167(2):966-75. PubMed ID: 11441105 [TBL] [Abstract][Full Text] [Related]
14. Neural mediation of vasoactive intestinal polypeptide inhibitory effect on jejunal alanine absorption. Barada KA; Saadé NE; Atweh SF; Nassar CF Am J Physiol; 1998 Oct; 275(4):G822-8. PubMed ID: 9756514 [TBL] [Abstract][Full Text] [Related]
15. Effects of pulmonary surfactant on macrophage migration: suppression of chemokinesis by surfactant phospholipid and enhancement of chemotaxis by surfactant protein. Tanaka F; Suga M; Nishikawa H; Muranaka H; Ando M Respirology; 1997 Jun; 2(2):119-26. PubMed ID: 9441123 [TBL] [Abstract][Full Text] [Related]
16. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide modulate endotoxin-induced IL-6 production by murine peritoneal macrophages. Martínez C; Delgado M; Pozo D; Leceta J; Calvo JR; Ganea D; Gomariz RP J Leukoc Biol; 1998 May; 63(5):591-601. PubMed ID: 9581803 [TBL] [Abstract][Full Text] [Related]
18. [Effects of vasoactive intestinal peptide on LPS-induced MMP-9 expression by alveolar macrophages in rats]. Liu YP; Guan CX; Bai HB; Qin XQ; Liu HJ Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Dec; 30(6):645-9. PubMed ID: 16708801 [TBL] [Abstract][Full Text] [Related]
19. VIP impairs acquisition of the macrophage proinflammatory polarization profile. Carrión M; Pérez-García S; Martínez C; Juarranz Y; Estrada-Capetillo L; Puig-Kröger A; Gomariz RP; Gutiérrez-Cañas I J Leukoc Biol; 2016 Dec; 100(6):1385-1393. PubMed ID: 27381006 [TBL] [Abstract][Full Text] [Related]
20. VIP and PACAP differentially regulate the costimulatory activity of resting and activated macrophages through the modulation of B7.1 and B7.2 expression. Delgado M; Sun W; Leceta J; Ganea D J Immunol; 1999 Oct; 163(8):4213-23. PubMed ID: 10510358 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]